Sunil Patel
2017
In 2017, Sunil Patel earned a total compensation of $1.7M as Former Executive Vice President and Chief Financial Officer at OncoMed Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $167,780 |
|---|---|
| Option Awards | $939,700 |
| Salary | $406,117 |
| Stock Awards | $183,600 |
| Total | $1,697,197 |
Patel received $939.7K in option awards, accounting for 55% of the total pay in 2017.
Patel also received $167.8K in non-equity incentive plan, $406.1K in salary and $183.6K in stock awards.
Rankings
In 2017, Sunil Patel's compensation ranked 6,336th out of 14,666 executives tracked by ExecPay. In other words, Patel earned more than 56.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,336 out of 14,666 | 57th |
Division Manufacturing | 2,332 out of 5,772 | 60th |
Major group Chemicals And Allied Products | 739 out of 2,075 | 64th |
Industry group Drugs | 572 out of 1,731 | 67th |
Industry Pharmaceutical Preparations | 451 out of 1,333 | 66th |
Source: SEC filing on April 27, 2018.
Patel's colleagues
We found four more compensation records of executives who worked with Sunil Patel at OncoMed Pharmaceuticals in 2017.